This entity has not been resolved onto another DFX graph by a shared identifier. A name match elsewhere would be a candidate, never an identity, and none is recorded.

Form D industry group

Pharmaceuticals

Rounds

1

Latest round

Form D equity offering 2025-08-21

Latest round amount

$20.0M

Investors

2

People

4

Revenue range

Decline to Discloseas stated on Form D

Website

quralis.com

• Occurred

  Sep 5, 2025
  Form D filed

  QurAlis Corp filed Form D: $19,952,387 sold of $24,921,734, Pharmaceuticals

  Form Dobserved 6 days ago
  $20.0M

Also named here, with no published line of their own (reach them through the firm): Shafique C.D. Virani (Executive Officer), Jason C.D. Brown (Mr. Brown is the Chief Financial Officer of the Issuer.), Kasper C.D. Roet (Mr. Roet is the Chief Executive Officer, President and Treasurer of the Issuer.), Michael C.D. Hutton (Director), Anne C.D. Whitaker (Director), Laia C.D. Crespo-Martin (Director), LUC C.D. Dochez (Director), Cillian C.D. King (Director), AMY C.D. Schulman (Director), Johannes C.D. Fruehauf (Director).

Who to call is the organisation, the person's role and the line they published themselves: a business phone, office address, website or profile link from Form ADV, Form 13F or their own website, with that source named on every value. The counts above are what a reveal returns; a personal email is rarely published, so most reveals are the firm's line. Never data bought from a provider, never anything personal. Reveals by plan

Graph

Venture Capital

Canonical id

dfx:vc:0919f413-433a-462e-87a6-7abeb8406d14

First observed

Sep 12, 2026

Last observed

Sep 17, 2026 40 h ago

Resolution

Identity across graphs by shared identifier (CRD, CIK, EIN, ADV fund id, individual CRD) or citation; a name match is shown as a candidate and never merged.